Unique transdermal absorption formulation technology using ionic liquids.
Our company has successfully developed a unique transdermal formulation technology called 'ILTS(R) (Ionic Liquid Transdermal System)' that utilizes the characteristics of ionic liquids. This technology dramatically improves the transdermal permeability of various drugs, including poorly soluble drugs and high-molecular substances such as nucleic acids and peptides, which were difficult to absorb transdermally with conventional techniques. Ionic liquids are salts that have a melting point below 100°C and are also referred to as room-temperature molten salts. They possess characteristics such as low melting point, high ionic conductivity, high polarity, non-volatility, and non-flammability, and their applications are being explored in various fields, including solar cells and environmentally friendly reaction solvents. [Accumulated Know-How] - A library of ionic liquids considered to have high safety due to combinations of compounds with a proven track record of use in humans. - Expertise in selecting ionic liquids suitable for enhancing the transdermal permeability of target drugs. - Know-how for formulating ionic liquids containing drugs into user-friendly forms (such as patches or ointments) while retaining their properties. *For more details, please feel free to contact us.*
Inquire About This Product
basic information
For more details, please feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our group consists of two companies: our company and our consolidated subsidiary, MEDRx USA INC. We are a drug discovery company group that creates new pharmaceuticals based on our unique transdermal drug delivery technology. Focusing on our proprietary transdermal drug delivery technologies, ILTS® (Ionic Liquid Transdermal System) and NCTS® (Nano-sized Colloid Transdermal System), we aim to maximize drug efficacy, reduce side effects, prevent missed doses, and enable administration to patients for whom oral administration is difficult, thereby creating pharmaceuticals with new added value.
